Pharmacokinetics of 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol (CTHC) After Intravenous Administration of CTHC in Healthy Human Subjects
about
Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THCInterindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9.Assessing cannabis consumption frequency: Is the combined use of free and glucuronidated THCCOOH blood levels of diagnostic utility?An in vitro experiment on the interaction of charcoal or wheat bran with 11-nor-9-carboxy-Δ9-tetrahydrocannabinol and its glucuronide
P2860
Pharmacokinetics of 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol (CTHC) After Intravenous Administration of CTHC in Healthy Human Subjects
description
im April 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2007
@uk
name
Pharmacokinetics of 11-nor-9-C ...... CTHC in Healthy Human Subjects
@en
Pharmacokinetics of 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol
@nl
type
label
Pharmacokinetics of 11-nor-9-C ...... CTHC in Healthy Human Subjects
@en
Pharmacokinetics of 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol
@nl
prefLabel
Pharmacokinetics of 11-nor-9-C ...... CTHC in Healthy Human Subjects
@en
Pharmacokinetics of 11-nor-9-Carboxy-Δ9-Tetrahydrocannabinol
@nl
P2093
P2860
P921
P356
P1476
Pharmacokinetics of 11-nor-9-C ...... CTHC in Healthy Human Subjects
@en
P2093
A Glaz-Sandberg
H Oberwittler
Rolf Aderjan
P2860
P356
10.1038/SJ.CLPT.6100199
P407
P50
P577
2007-04-04T00:00:00Z